Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2019 ,inter alia, to consider and approve 1) Standalone and Consolidated Audited Financial Results for the Quarter and Year ended March 31, 2019 as per Regulation 33 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015. 2) Any other business with the permission of chair.

Pdf Link: Vivanza Biosciences Ltd - Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31, 2019.

Source : BSE - www.bseindia.com

comment COMMENT NOW